对多种被忽视的热带疾病的口服药物治疗:系统性审查
Madhuri Reddy1, Sudeep S Gill, Sunila R Kalkar
1Department of Medicine, Hebrew Rehabilitation Center, Boston, Massachusetts 02131, USA. madhurireddy@hrca.harvard.edu
JAMA
|October 24, 2007
概括
同时的口服药物治疗可以有效地管理多种被忽视的热带疾病,提高效率并减少疾病负担. 提高对这些可治疗疾病的认识对于全球控制工作至关重要.
科学领域:
- 热带医学是一种热带医学.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 被忽视的热带疾病 (NTDs) 是贫困地区普遍存在的促进贫困的条件.
- NTDs造成的疾病负担相当严重,相当于艾滋病毒/艾滋病,结核病和疟疾.
- 七种常见的NTD已经存在口服药物治疗,具有潜在的多种疾病疗效.
研究的目的:
- 系统地审查有关NTD口服药物治疗的证据.
- 提高对NTD存在和可治疗性的认识.
主要方法:
- 从1966年到2007年6月发表的随机对照试验 (RCT) 的系统综述.
- 搜索了MEDLINE数据库的RCT,这些RCT检查了七种最常见的NTD中的两个或两个以上的同时治疗.
- 专注于口服药物治疗.
主要成果:
- 确定了29个RCT,其治疗同时针对2到4种疾病.
- 组合疗法,如阿尔本达结合二甲基马зин,阿尔本达结合艾弗梅克丁,以及莱瓦米索结合梅本达,显示出疾病患病率的显著降低.
- 单一药物治疗,如单独使用阿尔本达,也证明了对多种虫感染的有效性.
结论:
- 现有的口服药物治疗可以有效地同时针对多种普遍的被忽视的热带疾病.
- 同时的治疗策略提高了治疗效率,减少了疾病负担.
- 提高全球对NTD和可用的口腔疗法的认识对于疾病控制至关重要.
相关概念视频
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


